UPDATE 1-FDA OKs Abilify for child autism irritability

UPDATE 1-FDA OKs Abilify for child autism irritability
Reuters - 7 hours ago
LOS ANGELES, Nov 20 (Reuters) - The US Food and Drug Administration has approved Bristol-Myers Squibb Co's (BMY.N) and Otsuka Pharmaceutical Co's anti-psychotic drug Abilify to treat irritability ...
US Food and Drug Administration Approves ABILIFY® (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years) - Earthtimes
FDA Approves Bristol-Myers' Abilify To Treat Irritabilty In Pediatric Patients With Autistic Disorder - Update - RTT News
StreetInsider.com
- News-Medical.net